tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Compare Paradigm Biopharmaceuticals (PAR) vs. Competitors

39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.33
AU$103.91M
-1.51
-24.59%
Amplia Therapeutics
AU$0.14
AU$79.53M
-3.83
176.79%
Actinogen Medical
AU$0.04
AU$136.48M
-4.28
35.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Dimerix Limited
AU$0.36
AU$216.14M
-5.17
-9.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
Botanix Pharmaceuticals Limited
AU$0.04
AU$94.79M
-2.00
-90.27%
2 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.41
AU$138.81M
-2.84
61.62%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.23
-0.06
-20.69%
AU:ATX
Amplia Therapeutics
0.16
0.10
198.08%
AU:ACW
Actinogen Medical
0.04
<0.01
26.67%
AU:DXB
Dimerix Limited
0.34
-0.06
-15.00%
AU:BOT
Botanix Pharmaceuticals Limited
0.04
-0.32
-89.86%
AU:RCE
Recce Pharmaceuticals Ltd.
0.48
0.19
67.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts